2005•Fertility and SterilityOpen access

Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

Bart C.J.M. Fauser, Paul Devroey

Open full text 75 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 75 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Controlled ovarian hyperstimulation, In vitro fertilisation, Agonist, Antagonist, Ovarian hyperstimulation syndrome, Gonadotropin-releasing hormone antagonist, Medicine, Gonadotropin

Back to paper search Browse research topics Original source

Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? — Research Paper | ScholarLens